Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary Hyperhidrosis
Public ClinicalTrials.gov record NCT02129660. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind Vehicle-Controlled Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary Hyperhidrosis
Study identification
- NCT ID
- NCT02129660
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Journey Medical Corporation
- Industry
- Enrollment
- 105 participants
Conditions and interventions
Conditions
Interventions
- Dose 1 of glycopyrrolate, 2.0% QD Drug
- Dose 2 of glycopyrrolate, 3.0% QD Drug
- Dose 1 of glycopyrronium, 2.5% QD Drug
- Dose 2 of glycopyrronium, 3.75% QD Drug
- Vehicle Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2014
- Primary completion
- Dec 31, 2014
- Completion
- Dec 31, 2014
- Last update posted
- Sep 16, 2025
2014 – 2015
United States locations
- U.S. sites
- 14
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| California Dermatology & Clinical Research Institute | Encinitas | California | 92024 | — |
| Center For Dermatology Clinical Research | Fremont | California | 94538 | — |
| Olympian Clinical Research | Tampa | Florida | 33609 | — |
| Kenneth R. Beer MD | West Palm Beach | Florida | 33401 | — |
| Shideler Clinical Research Center | Carmel | Indiana | 46032 | — |
| Saint Louis University Dermatology | St Louis | Missouri | 63122 | — |
| Haber Dermatology and Cosmetic Surgery | Beachwood | Ohio | 44122 | — |
| Rivergate Dermatology Clinical Research Center, PLLC | Goodlettsville | Tennessee | 37072 | — |
| DermResearch, Inc | Austin | Texas | 78759 | — |
| Dermatology Research Center, Inc. | Salt Lake City | Utah | 84117 | — |
| Virginia Clinical Research, Inc. | Norfolk | Virginia | 23507 | — |
| Dermatology Associates | Seattle | Washington | 98101 | — |
| Women's Clinical Research Center | Seattle | Washington | 98105 | — |
| Premier Clinical Research | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02129660, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 16, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02129660 live on ClinicalTrials.gov.